Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) To Commence Construction of New Advanced Development Center In Massachusetts

Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) plans to hold a groundbreaking ceremony at its planned 45,000 sq. ft. clinical scale manufacturing plant in the New Bedford Business Park, Massachusetts, on August 3, 2021. 

Tonix building a new Advance Development Centre in Massachusetts 

Tonix’s Advanced Development Center (ADC) will be housed at the new facility, used for expedited R&D and analytical capabilities and the manufacture of clinical study grade vaccines for infectious diseases, such as COVID-19. The ceremony marks the official commencement of the building on the site. The facility is expected to be operational in 1H 2022, according to Tonix.

Single-use bioreactors and purification suites are planned for the ADC and equipment for GMP vaccine manufacturing for clinical trials, including the capacity to produce sterile vaccines in glass bottles once fully operational. The ADC is designed to be a Biosafety Level 2 facility and may employ up to 70 scientists, researchers, manufacturers, and technical support employees at full capacity.

U.S. Representative Bill Keating, Massachusetts Housing and Economic Development Secretary Mike Kennealy, New Bedford Mayor Jon Mitchell, and Seth Lederman, M.D., President and Chief Executive Officer of Tonix, will attend the celebration.

ADC to enhance Tonix’s manufacturing capacity 

Lederman said, “The ADC is expected to greatly enhance our internal capacity for development activities, but, even more importantly, add a manufacturing capability for clinical trial quality vaccines. We at Tonix are grateful to the Town of Dartmouth for their support. We also thank the City of New Bedford for its cooperation with the Town of Dartmouth on this project. The initiation of construction is a significant milestone in ultimately adding to our competitive advantage in responding quickly to emerging infectious diseases utilizing our growing range of vaccine technologies and protein-based therapeutic platforms.”

Keating commented, “Tonix Pharmaceuticals is bringing good jobs to our region, and I look forward to watching their growth as the local economy continues to benefit from increased investment on the South Coast, including in South Coast Rail.”